NVNO PE Ratio & Valuation,Is NVNO Overvalued

NVNO Relative Valuation

NVNO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVNO is overvalued; if below, it's undervalued.

Historical Valuation

enVVeno Medical Corp (NVNO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.46. The fair price of enVVeno Medical Corp (NVNO) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：0.31

Fair

-0.30

0.00

EV/EBITDA

enVVeno Medical Corp. (NVNO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.95

EV/EBIT

enVVeno Medical Corp. (NVNO) has a current EV/EBIT of 0.95. The 5-year average EV/EBIT is -0.83. The thresholds are as follows: Strongly Undervalued below -2.99, Undervalued between -2.99 and -1.91, Fairly Valued between 0.25 and -1.91, Overvalued between 0.25 and 1.34, and Strongly Overvalued above 1.34. The current Forward EV/EBIT of 0.95 falls within the Overvalued range.

4.23

enVVeno Medical Corp. (NVNO) has a current PS of 4.23. The 5-year average PS is 42.81. The thresholds are as follows: Strongly Undervalued below -81.34, Undervalued between -81.34 and -19.27, Fairly Valued between 104.88 and -19.27, Overvalued between 104.88 and 166.96, and Strongly Overvalued above 166.96. The current Forward PS of 4.23 falls within the Historic Trend Line -Fairly Valued range.

-0.42

P/OCF

enVVeno Medical Corp. (NVNO) has a current P/OCF of -0.42. The 5-year average P/OCF is -6.97. The thresholds are as follows: Strongly Undervalued below -54.64, Undervalued between -54.64 and -30.81, Fairly Valued between 16.86 and -30.81, Overvalued between 16.86 and 40.70, and Strongly Overvalued above 40.70. The current Forward P/OCF of -0.42 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

enVVeno Medical Corp. (NVNO) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.33. The thresholds are as follows: Strongly Undervalued below -4.46, Undervalued between -4.46 and -2.39, Fairly Valued between 1.73 and -2.39, Overvalued between 1.73 and 3.80, and Strongly Overvalued above 3.80. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

enVVeno Medical Corp (NVNO) has a current Price-to-Book (P/B) ratio of 0.21. Compared to its 3-year average P/B ratio of 1.38 , the current P/B ratio is approximately -84.67% higher. Relative to its 5-year average P/B ratio of 1.40, the current P/B ratio is about -84.91% higher. enVVeno Medical Corp (NVNO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -44.48%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -35.86% , the current FCF yield is about -100.00% lower.

0.22

P/B

Median3y

1.38

Median5y

1.40

-271.57

FCF Yield

Median3y

-44.48

Median5y

-35.86

Competitors Valuation Multiple

The average P/S ratio for NVNO's competitors is 0.00, providing a benchmark for relative valuation. enVVeno Medical Corp Corp (NVNO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of NVNO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of NVNO in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is enVVeno Medical Corp (NVNO) currently overvalued or undervalued?

What is enVVeno Medical Corp (NVNO) fair value?

NVNO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of enVVeno Medical Corp (NVNO) is between to according to relative valuation methord.

How does NVNO's valuation metrics compare to the industry average?

What is the current P/B ratio for enVVeno Medical Corp (NVNO) as of Dec 17 2025?

As of Dec 17 2025, enVVeno Medical Corp (NVNO) has a P/B ratio of 0.21. This indicates that the market values NVNO at 0.21 times its book value.

What is the current FCF Yield for enVVeno Medical Corp (NVNO) as of Dec 17 2025?

As of Dec 17 2025, enVVeno Medical Corp (NVNO) has a FCF Yield of 0.00%. This means that for every dollar of enVVeno Medical Corp’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for enVVeno Medical Corp (NVNO) as of Dec 17 2025?

As of Dec 17 2025, enVVeno Medical Corp (NVNO) has a Forward P/E ratio of -0.28. This means the market is willing to pay $-0.28 for every dollar of enVVeno Medical Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for enVVeno Medical Corp (NVNO) as of Dec 17 2025?

As of Dec 17 2025, enVVeno Medical Corp (NVNO) has a Forward P/S ratio of 0.00. This means the market is valuing NVNO at $0.00 for every dollar of expected revenue over the next 12 months.

NVNO Valuation